BD
SummitIn person
BioPharma Deals BD&L Summit 2026
Hosted by BioPharma Deals
- 24 – 25 November 2026
Add to calendar
Welcome to kongre.net - Science Congress Center Munich, Munich, Germany
- Medical & Health Sciences, Business, Economics & Law
Let others know you'll be there. This does not register you for the event.
Welcome to kongre.net
Welcome to kongre.net
Key facts
BioPharma Deals BD&L Summit 2026 is a summit held 24 – 25 November 2026 in Science Congress Center Munich, Munich, Germany, organised by BioPharma Deals.
- Dates:
- 24 – 25 November 2026
- Format:
- In person
- Venue:
- Science Congress Center Munich, Munich, Germany
- Subjects:
- Medical & Health Sciences, Business, Economics & Law
- Organiser:
- BioPharma Deals
- Official website:
- biopharmadeals.com
The BioPharma Deals Conference unites global biopharma executives, investors, and dealmakers to explore licensing opportunities, strategic partnerships, co-development, M&A, and commercial collaborations.
Conference theme
Europe's Premier Life Sciences Dealmaking Summit
Objectives
To discover transformative opportunities, strategic partnerships, and high value deals, accelerating innovation and business growth in life sciences.
Who should attend
Senior-level BD&L leaders from pharma, biotech & life sciences, including Chief BD Officers, biotech CEOs, life sciences investors, licensing directors, M&A leaders, and legal/IP advisors.
Programme highlights
View full programmeSpeakers
View speakers- Dimitri F. Dimitriou - Managing Director, DyoDelta Biosciences Ltd.
- Caroline Robic - R&D Due Diligence Director, Servier
- Dr. Ralf Angermund - Director Search & Evaluation Germany, External Scientific Innovation, Johnson & Johnson Innovative Medicine
- Benjamin August - Senior Director, Search & Evaluation - Research & Technologies, Daiichi Sankyo
- Berthold Hinzen, Ph. D. - Corporate & Business Development, Global Head of Due Diligence, Novartis
- Akiko Tanabe - Scouting & Transaction Lead, Business Development, Astellas Pharma Europe
- Dr. Vinay Pawar - Scientific Director (Data and AI), R&D External Innovation, Novo Nordisk
- Isabelle Scarabin - Director, Business Licensing Officer & Alliance Manager, Bayer
- Monika Baudler-Klein - Executive Director, Alliance & Assetmanagement, Pharma Partnering, Roche
- Ricardo Gaminha Pacheco, MD MBA MPH - Longevity Biotechnology Strategic Partnering, BD&L Senior Director, Insilico Medicine
- Christian Kuttruff - Director, Global Business Development & Licensing, Boehringer Ingelheim
- Martin Svorc - Director, Neurology & Immunology, Business Development & AI Strategy and Enablement Lead, Merck
Organiser and contact
Host organisation
BioPharma DealsContact
- Email:
- [email protected]
Advertisement
Related events
- 23rd Meeting of the European Association for Haematopathology (EA4HP-SH 2026)Berlin, Germany3–8 Oct 2026
- Life Science Legal Strategy Summit 2026Frankfurt, Germany13–14 Oct 2026
- V Euro Anesthesiology and Critical Care CongressBerlin, Germany19–20 Oct 2026
- V Euro HeartCare and Cardiovascular Medicine ConferenceBerlin, Germany19–20 Oct 2026
- EACR Conference: Chromosomes in Crisis – From Chromosomal Instability to Catastrophes in Cancer GenomesBerlin, Germany3–5 Nov 2026
- MEDICA 2026Düsseldorf, Germany16–19 Nov 2026